NOVOBIOTIC PHARMACEUTICALS LLC has a total of 42 patent applications. It increased the IP activity by 350.0%. Its first patent ever was published in 2008. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BIOSTEED GENE EXPRESSION TECH CO LTD, CYPRALIS LTD and CYTHERIS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Australia | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Canada | 4 | |
#6 | Taiwan | 3 | |
#7 | China | 2 | |
#8 | Hong Kong | 2 | |
#9 | Japan | 2 | |
#10 | Argentina | 1 | |
#11 | Brazil | 1 | |
#12 | Chile | 1 | |
#13 | Mexico | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Climate change adaptation technologies | |
#5 | Microorganisms | |
#6 | Fermentation | |
#7 | Heterocyclic compounds | |
#8 | Microorganisms | |
#9 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Lewis Kim | 35 |
#2 | Ling Losee Lucy | 34 |
#3 | Nitti Anthony | 23 |
#4 | Hughes Dallas | 23 |
#5 | Spoering Amy | 23 |
#6 | Millett William | 22 |
#7 | Epstein Slava | 21 |
#8 | Peoples Aaron J | 18 |
#9 | Steadman Victoria Alexandra | 16 |
#10 | Jones Michael Kenyon | 16 |
Publication | Filing date | Title |
---|---|---|
US2021052693A1 | Pharmaceutical compositions comprising teixobactin | |
WO2018187173A1 | Novel depsipeptides and uses thereof | |
WO2017147003A1 | Novel macrocyclic antibiotics and uses thereof | |
CA2890933A1 | Novel depsipeptide and uses thereof | |
EP2713728A1 | Novel antibiotics | |
US2011136752A1 | Novel antibiotics | |
WO2009110938A2 | Novel macrocyclic polyene lactams | |
WO2009026527A1 | Novel macrolactam compounds |